A biomimetic renal fibrosis progression model on-chip evaluates anti-fibrotic effects longitudinally in a dynamic fibrogenic niche
D Wu, J Wu, H Liu, S Shi, L Wang, Y Huang, X Yu… - Lab on a Chip, 2023 - pubs.rsc.org
Although renal fibrosis can advance chronic kidney disease and progressively lead to end-
stage renal failure, no effective anti-fibrotic drugs have been clinically approved. To aid drug …
stage renal failure, no effective anti-fibrotic drugs have been clinically approved. To aid drug …
A biomimetic renal fibrosis progression model on-chip evaluates anti-fibrotic effects longitudinally in a dynamic fibrogenic niche.
D Wu, J Wu, H Liu, S Shi, L Wang, Y Huang, X Yu… - Lab on a …, 2023 - europepmc.org
Although renal fibrosis can advance chronic kidney disease and progressively lead to end-
stage renal failure, no effective anti-fibrotic drugs have been clinically approved. To aid drug …
stage renal failure, no effective anti-fibrotic drugs have been clinically approved. To aid drug …
A biomimetic renal fibrosis progression model on-chip evaluates anti-fibrotic effects longitudinally in a dynamic fibrogenic niche
D Wu, J Wu, H Liu, S Shi, L Wang, Y Huang… - Lab on a …, 2023 - pubmed.ncbi.nlm.nih.gov
Although renal fibrosis can advance chronic kidney disease and progressively lead to end-
stage renal failure, no effective anti-fibrotic drugs have been clinically approved. To aid drug …
stage renal failure, no effective anti-fibrotic drugs have been clinically approved. To aid drug …